MarketPulse

neuroinflammation

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Tiziana Life Sciences

Tiziana's Long COVID Treatment Shows Promise in Peer-Reviewed Study

Tiziana Life Sciences reports positive preclinical data for intranasal foralumab in treating Long COVID neuroinflammation and cognitive dysfunction.
TLSAALSAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Roche's New Blood Test for MS Neuroinflammation Gets EU Green Light

Roche receives CE mark for Elecsys NfL blood test detecting neuroinflammation in relapsing-remitting multiple sclerosis, offering minimally invasive alternative to MRI monitoring.
RHHBYmultiple sclerosispatient monitoring
GlobeNewswire Inc.GlobeNewswire Inc.··Inmune Bio Inc.

INmune Bio's Alzheimer's Trial Wins Spotlight as Model for Inflammation-Targeting Approach

INmune Bio's XPro trial gains recognition at AD/PD 2026 for innovative biomarker-enriched Alzheimer's approach, securing FDA approval to advance to Phase 2b/3 registrational studies.
INMBclinical trialAlzheimer's disease
neuroinflammation News | MarketPulse